José F. Leis

Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

Tait D. Shanafelt, Xin V. Wang, Neil E. Kay et al. · New England Journal of Medicine · 2019 · 715 citations · Full text

Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL

Wei Ding, Betsy LaPlant, Timothy G. Call et al. · Blood · 2017 · 411 citations · Full text

Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial

Craig B. Reeder, Donna Reece, Vishal Kukreti et al. · Leukemia · 2009 · 369 citations · Full text

Hematological Malignancy, Health Sciences, Medicine +8

Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning for Advanced Chronic Lymphocytic Leukemia

Mohamed L. Sorror, Michael B. Maris, Brenda M. Sandmaier et al. · Journal of Clinical Oncology · 2005 · 231 citations · Full text

Diffuse large <scp>B</scp>‐cell lymphoma (<scp>R</scp>ichter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients

Sameer A. Parikh, Kari G. Rabe, Timothy G. Call et al. · British Journal of Haematology · 2013 · 220 citations · Full text